Life Sciences Industry IT Spending Forecast in Japan through 2014

Introduction

As pharmaceutical and biotechnology companies increasingly turn to IT to reduce costs and the time-to-market of a drug, it is important for technology vendors to understand where growth opportunities exist in the global life science market. This Databook provides a forecast and analysis of IT spending in the pharma/biotech industries through to 2014.

Scope

*Forecast of IT spending within the Japan pharmaceutical and biotechnology markets by sector, and IT segments (hardware, software, services)

*Sectors covered are Big Pharma, Mid Pharma, Big Biotech, and Small Pharma & Biotech

Highlights

Although the current economic climate and credit crunch has halted major IT projects for a couple of years, technology investments will continue to grow on a worldwide basis over the next five years, particularly in the biotechnology sector which is becoming a core area of research for future drugs.

Big Pharma will spend the highest amount of money on IT as they are turning to technology solutions to increase efficiencies within the drug lifecycle, reduce costs, and bring the drug to market faster, but the overall CAGR will be the lowest of the four sectors.

Once companies have the appropriate hardware technologies in place, they will begin to spend a larger portion of their budget on software and services.

Reasons to Purchase

*Understand the opportunity size for technology spending in the life sciences industry

*Identify potential areas for spending growth amongst pharmaceutical and biotechnology companies

*Segment the life science industry by spending opportunities


Report Highlights

[Studien Infos ausblenden]

TABLE OF CONTENTS
OVERVIEW 1
Catalyst 1
Summary 1
INTRODUCTION 5
Reasons to purchase 5
LIFE SCIENCES IT SPENDING FORECAST IN JAPAN 6
Life sciences IT spending overview to 2014 6
Life sciences IT spending by sector to 2014 7
LIFE SCIENCES IT SPENDING BY SECTOR 9
Big Pharma sector IT spending by segment to 2014 9
Mid Pharma sector IT spending by segment to 2014 11
Big Biotech sector IT spending by segment to 2014 13
Small Pharma and Biotech sector IT spending by segment to 2014 15
LIFE SCIENCES IT SPENDING FORECAST IN ASIA PACIFIC 17
IT spending comparison by country, 2008 17
IT spending by sector to 2014 19
APPENDIX 21
Methodology 21
Further reading 22
How to contact experts in your industry 22
Disclaimer 22

LIST OF FIGURES
Figure 1: Life sciences industry, Japan, IT spending by sector ($m), 2008–14 7
Figure 2: Big Pharma sector, Japan, IT spending by segment ($m), 2008–14 9
Figure 3: Mid Pharma sector, Japan, IT spending by segment ($m), 2008–14 11
Figure 4: Big Biotech sector, Japan, IT spending by segment ($m), 2008–14 13
Figure 5: Small Pharma and Biotech sector, Japan, IT spending by segment ($m), 2008–14 15
Figure 6: Life sciences industry, Asia Pacific, IT sending comparison by country (%), 2008 17
Figure 7: Life sciences industry, Asia Pacific, IT sending comparison by sector ($m and %share), 2008–14 19
Figure 8: Life sciences IT spending, forecast methodology flowchart 21

LIST OF TABLES
Table 1: Life sciences IT spending data specifications 5
Table 2: Life sciences industry, Japan, IT spending ($m), 2008–14 6
Table 3: Life sciences industry, Japan, IT spending by sector ($m), 2008–14 8
Table 4: Big Pharma sector, Japan, IT spending by segment ($m), 2008–14 10
Table 5: Mid Pharma sector, Japan, IT spending by segment ($m), 2008–14 12
Table 6: Biotech sector, Japan, IT spending by segment ($m), 2008–14 14
Table 7: Small Pharma and Biotech sector, Japan, IT spending by segment ($m), 2008–14 16
Table 8: Life sciences industry, Asia Pacific, IT sending comparison by country ($m and % share), 2008 18
Table 9: Life sciences industry, Asia Pacific, IT sending comparison by sector ($m), 2008–14 20



[Inhaltsverzeichnis ausblenden]